drugset / Trial / NCT00378066
Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the efficacy and safety of bevacizumab/capecitabine/oxaliplatin combination in metastatic or recurrent Korean colorectal cancer.
Timeline
- Start
- 2006-08
- Primary completion
- 2006-08
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bevacizumab | Monoclonal antibody | — | — |
| Comparator | Capecitabine | Small molecule | — | — |
| Comparator | Oxaliplatin | Small molecule | — | — |